However, Roniciclib affected the protein and mRNA levels of both CDK2 and CDK4 in the MCF7 breast cancer cells after a treatment for 72 h (RT-PCR P = 0.008 and 0.022, respectively, Supplementary Fig. S7B). This evidence concerns the gene CDK2 and breast carcinoma.